Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00571389 · ClinicalTrials.gov registry record
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
A clinical trial of Solid Tumor, Adult and Healthy Donors, sponsored by BioCytics.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT00571389: Recruiting study of Solid Tumor, Adult and Healthy Donors, sponsored by BioCytics.
NCT00571389 is a study of Solid Tumor, Adult and Healthy Donors that is actively recruiting participants, run by BioCytics. The registered enrollment target is 1,500 participants, above the 170-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (782% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00571389, a study of Solid Tumor, Adult and Healthy Donors, is actively recruiting participants, sponsored by BioCytics.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objective: This is a study to investigate the feasibility of harvesting, expanding, and selecting T lymphocytes from cancer patients and healthy volunteers. The preliminary objective of this study is aimed at selecting PD-1+ and CTLA4+ T cells and other cellular fractions from peripheral blood of cancer patients and healthy volunteers by using specific conjugated antibodies, evaluating their functional ex vivo anti-tumor cytotoxicity against targeted autologous tumor cells.
Conditions Studied
Study Locations (1)
North Carolina
- Carolina BioOncology Institute - Huntersville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2007-11 |
| Est. Completion | 2030-02 |
What NCT00571389 shows while recruiting
NCT00571389 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 170-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (782% higher).
The record links to 3 conditions, with Solid Tumor, Adult appearing as the primary indexed condition, and to 0 interventions.
NCT00571389 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00571389 about?
NCT00571389 is a clinical study titled "A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.". Primary Objective: This is a study to investigate the feasibility of harvesting, expanding, and selecting T lymphocytes from cancer patients and healthy volunteers. The preliminary objective of this study is aimed at selecting PD-1+ and CTLA4+ T cells and other cellular fractions from peripheral bl...
What is the current status of trial NCT00571389?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2007-11. Estimated completion is 2030-02.
What conditions does trial NCT00571389 study?
This clinical trial studies the following conditions: Solid Tumor, Adult, Healthy Donors, COVID-19 Donors.
Who is sponsoring clinical trial NCT00571389?
This trial is sponsored by BioCytics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00571389 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00571389's enrollment target sits among peer trials
1,500 1st of 72 higher than 72 of 72 other Solid Tumor, Adult trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Solid Tumor, Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
RECRUITING · NA
-
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RECRUITING · Phase 1
-
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
RECRUITING · Phase 1
-
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
-
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia